NCT00686868 - Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 13, 2008

Primary Completion Date

March 11, 2011

Study Completion Date

May 2, 2011

Conditions

Arthritis, Rheumatoid

Interventions

OTHER

placebo

DRUG

ofatumumab

fully human anti-CD20 monoclonal antibody

Trial Locations (17)

1200

GSK Investigational Site, Brussels

2031

GSK Investigational Site, Randwick

3000

GSK Investigational Site, Leuven

3004

GSK Investigational Site, Melbourne

3084

GSK Investigational Site, Heidelberg

5000

GSK Investigational Site, Adelaide

8011

GSK Investigational Site, Christchurch

28046

GSK Investigational Site, Madrid

33025

GSK Investigational Site, Miramar

36207

GSK Investigational Site, Anniston

37126

GSK Investigational Site, Verona

38130

GSK Investigational Site, Échirolles

85168

GSK Investigational Site, Bydgoszcz

115522

GSK Investigational Site, Moscow

150003

GSK Investigational Site, Yaroslavl

214018

GSK Investigational Site, Smolensk

390026

GSK Investigational Site, Ryazan